DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

0.91
Delayed Data
As of Apr 25
 -0.0353 / -3.73%
Today’s Change
0.78
Today|||52-Week Range
2.85
-16.51%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 9.30, with a high estimate of 12.00 and a low estimate of 6.60. The median estimate represents a +921.98% increase from the last price of 0.91.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in DelMar Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$0.00
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.14%
 
 
 
 
 
 
Growthannually 31.76%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.